Fluoroethyltyrosine in Detecting Tumors in Participants With Recurrent Intracranial Tumors
Summary
- Eligibility
- for people ages 3 years and up (full criteria)
- Location
- at San Francisco, California
- Dates
- study startedestimated completion
- Principal Investigator
- by Thomas A Hope, MD
Description
Summary
Official Title
Details
Keywords
Eligibility
Location
Lead Scientist at UCSF
- Thomas A Hope, MD
Thomas Hope, MD, is the Vice Chair of Clinical Operations and Strategy in the Department of Radiology. He also serves as the Director of Molecular Therapy. He serves as Chief of Nuclear Medicine at the San Francisco VA Medical Center and as chair of the Cancer Center’s Molecular Imaging & Radionuclide Therapy Site Committee.
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Thomas Hope
- ID
- NCT04044937
- Phase
- Phase 2 research study
- Study Type
- Interventional
- Participants
- Expecting 199 study participants
- Last Updated